Bio

Gregg has over 35 years of experience as a financier for emerging growth companies specializing in the healthcare sector. In 2016, he co-founded Healthgrowth Pharmacy Solutions, an advisory Company and Group Purchasing Organization for the 22,000 independent pharmacies in the U.S. From 2014-2016, he was a Managing Director and led the healthcare banking practice at Westlake Securities. Prior to that, he was the CEO and co-founder of Creation Capital LLC and Creation Capital Advisors, an investment banking firm and Broker Dealer with offices in New York City and Austin, Texas. Gregg has been instrumental in providing early stage capital for Myriad Genetics, Inc (symbol MYGN), one of the first molecular diagnostics companies, and was a co- founder of Acacia Biosciences which merged with Rosetta Inpharmatics, Inc. and acquired by Merck for $620 million. Gregg holds a BA in Economics from the University of Texas at Austin.